Tom Van Blarcom News Today

Throughout 2023, interest in the application of CAR-T and other cell therapies to autoimmune disease skyrocketed, with a multitude of clinical trials being initiated by various companies.

Today the winners of Italthai Portrait Prize 2023 were announced and awarded. Thailands national portraiture competition, now in its third year, continues to grow in entries from professional, amateur and student artists. This year, Italthai

A Times reporter’s new biography of Trump shows the boundlessness of his self-regard.

/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced...